Yemi Adekola Adekunle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yemi Adekola Adekunle has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Babatunde B. Samuel
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan, Nigeria
8 shared publications - Satyajit Dey Sarker
Centre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool L3 3AF, UK
6 shared publications - Amos Akintayo Fatokun
Centre for Natural Products Discovery (CNPD), School of Pharmacy and Biomolecular Sciences, Faculty of Health, Innovation, Technology and Science, Liverpool John Moores University, Liverpool L3 3AF, UK
5 shared publications - Lutfun Nahar
Laboratory of Growth Regulators, Palacký University and Institute of Experimental Botany, The Czech Academy of Sciences
5 shared publications - Adeniyi Thompson Adewumi
Department of Life and Consumer Sciences, Calabash Building, Room 02-026, University of South Africa, Johannesburg, South Africa
4 shared publications - Wande Michael Oluyemi
Department of Pharmaceutical and Medicinal Chemistry, College of Pharmacy, Afe Babalola University, Ado-Ekiti, Nigeria
4 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by MDPI AG in Preprints.org
Towards New Antidiabetic Development: Molecular Interactions Unfold Potential Agonistic Mechanisms of Naturally Occurring Terpenoids Against Structural Landscape of Glucagon-like Peptide-1 Receptor
Glucagon-like peptide-1 receptor (GLP-1R) is a focal target in antidiabetic drug discovery. Synthetic non-peptide compounds are routinely employed to investigate GLP-1R, however, scaffolds from natural products will offer us unique structural diversity to design more potent compounds. We investigated the potential of some natural compounds as agonists of GLP-1R. First, we carried out a virtual screening of 244 compounds, from 19 medicinal plants used in antidiabetic traditional medicine, against GLP-1R. We used molecular dynamics simulations, for 200ns, to further investigate the lead five compounds. Binding Free Energies (BFE), Root Mean Square Deviation (RMSD) and other parameters were employed to understand these interactions. Our results showed that lupeol (-57.23) had good BFE (kcal/mol) compared to danuglipron (-56.47), thus demonstrating more robust interactions with GLP-1R. The pocket-buried residues, CYS191 and GLN186, showed strong hydrogen bonds while the critical residue, TRP4, showed strong van der Waals interactions to stabilize the ligands. Moreover, the average RMSD (Å) of lupeol-bound GLP-1R (3.45) are comparable to danuglipron-bound GLP-1R (3.33), indicating good stability in the pocket. This potentially situates lupeol as GLP-1R agonist similar to danuglipron, and thus opens up the opportunity for more further experimental work, to validate its agonist properties on GLP1R.
- 3 November 2026
- Published by MDPI AG in Preprints.org
Open AccessTowards New Antidiabetic Development: Molecular Interactions Unfold Potential Agonistic Mechanisms of Naturally Occurring Terpenoids Against Structural Landscape of Glucagon-like Peptide-1 Receptor
Glucagon-like peptide-1 receptor (GLP-1R) is a focal target in antidiabetic drug discovery. Synthetic non-peptide compounds are routinely employed to investigate GLP-1R, however, scaffolds from natural products will offer us unique structural diversity to design more potent compounds. We investigated the potential of some natural compounds as agonists of GLP-1R. First, we carried out a virtual screening of 244 compounds, from 19 medicinal plants used in antidiabetic traditional medicine, against GLP-1R. We used molecular dynamics simulations, for 200ns, to further investigate the lead five compounds. Binding Free Energies (BFE), Root Mean Square Deviation (RMSD) and other parameters were employed to understand these interactions. Our results showed that lupeol (-57.23) had good BFE (kcal/mol) compared to danuglipron (-56.47), thus demonstrating more robust interactions with GLP-1R. The pocket-buried residues, CYS191 and GLN186, showed strong hydrogen bonds while the critical residue, TRP4, showed strong van der Waals interactions to stabilize the ligands. Moreover, the average RMSD (Å) of lupeol-bound GLP-1R (3.45) are comparable to danuglipron-bound GLP-1R (3.33), indicating good stability in the pocket. This potentially situates lupeol as GLP-1R agonist similar to danuglipron, and thus opens up the opportunity for more further experimental work, to validate its agonist properties on GLP1R.
- 19 September 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- p. 1-35
Integration of network pharmacology, structure-based pharmacophore modeling, DFT, molecular docking, and molecular dynamics simulations to identify multi-target small molecule inhibitors against Alzheimer’s disease
- 19 September 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- p. 1-35
Integration of network pharmacology, structure-based pharmacophore modeling, DFT, molecular docking, and molecular dynamics simulations to identify multi-target small molecule inhibitors against Alzheimer’s disease
- Open Access
- 24 August 2026
- Published by Springer Nature in Journal of Cheminformatics
- Vol. 18 (1) , 122
Computational applications in secondary metabolite discovery (CAiSMD) 2026: focus on secondary metabolites towards drug discovery
- 24 August 2026
- Published by Springer Nature in Journal of Cheminformatics
- Vol. 18 (1) , 122
Open AccessComputational applications in secondary metabolite discovery (CAiSMD) 2026: focus on secondary metabolites towards drug discovery
- Open Access
- 17 June 2025
- Published by Maad Rayan Publishing Company in Pharmaceutical Sciences
- Vol. 31 (3) , 294-303
Phytosterol Glycosides from Olaxsubscorpioidea Oliv. Exhibit Cytotoxic Effects in InVitro and InSilico Studies
Background: Olax subscorpioidea is traditionally used to treat arthritis, cancer, diabetes, neurodegenerative disorders, and oxidative stress. This study carried out chromatographic isolation, cytotoxicity, and molecular docking studies of bioactive compounds from O. subscorpioidea. Methods: The root of O. subscorpioidea was extracted with methanol using Soxhlet extraction method. The extract was partitioned into n-hexane, dichloromethane, and methanol/water. Dichloromethane fraction was subjected to column chromatography. Bioactive compounds were isolated and their chemical structures were established by 1D and 2D nuclear magnetic resonance (NMR) spectroscopy, and by comparing their NMR data with those previously reported in the literature. MTT assay was used to evaluate the cytotoxic activity of these compounds against three human cancer cell lines: breast (MCF-7), cervical (HeLa), and colorectal (Caco-2) cell lines. Molecular docking was used to gain insights into the favourable binding conformations and energies of the compounds when interacting with ten selected cancer-related protein targets. Results: The phytochemical investigation of the extract of O. subscorpioidea afforded two sterol glycosides, stigmast-5,22-dien-3-O-β-D-glucoside (1a) and sitosterol-3-O-β-D-glucoside (1b), as a mixture. The compounds were found to be active against HeLa (IC50: 37.0±4.51 µg/mL) and MCF-7 (137.07±19.43 µg/mL) cell lines. The compounds showed strong interactions with the colchicine-binding site on the β-subunit of tubulin protein, epidermal growth factor receptor kinase domain, poly(ADP-ribose) polymerase-1, and 17β-hydroxysteroid dehydrogenase type 1 (binding energies: –10.3 and –10.0 kcal/mol; –9.3 and –9.3 kcal/mol; –9.2 and –9.2 kcal/mol; and –9.3 and –9.1 kcal/mol, respectively). Stigmast-5,22-dien-3-O-β-D-glucoside was consistently ranked higher in some of the proteins tested. The compounds stabilised in the binding sites of the proteins via hydrogen bonds and hydrophobic interactions. Conclusion: To the best of our knowledge, this is the first report of the isolation of these compounds from this plant. The cytotoxic effects of O. subscorpioidea root extract could be partly attributed to stigmast-5,22-dien-3-O-β-D-glucoside and sitosterol-3-O-β-D-glucoside.
- 17 June 2025
- Published by Maad Rayan Publishing Company in Pharmaceutical Sciences
- Vol. 31 (3) , 294-303
Open AccessPhytosterol Glycosides from Olaxsubscorpioidea Oliv. Exhibit Cytotoxic Effects in InVitro and InSilico Studies
Background: Olax subscorpioidea is traditionally used to treat arthritis, cancer, diabetes, neurodegenerative disorders, and oxidative stress. This study carried out chromatographic isolation, cytotoxicity, and molecular docking studies of bioactive compounds from O. subscorpioidea. Methods: The root of O. subscorpioidea was extracted with methanol using Soxhlet extraction method. The extract was partitioned into n-hexane, dichloromethane, and methanol/water. Dichloromethane fraction was subjected to column chromatography. Bioactive compounds were isolated and their chemical structures were established by 1D and 2D nuclear magnetic resonance (NMR) spectroscopy, and by comparing their NMR data with those previously reported in the literature. MTT assay was used to evaluate the cytotoxic activity of these compounds against three human cancer cell lines: breast (MCF-7), cervical (HeLa), and colorectal (Caco-2) cell lines. Molecular docking was used to gain insights into the favourable binding conformations and energies of the compounds when interacting with ten selected cancer-related protein targets. Results: The phytochemical investigation of the extract of O. subscorpioidea afforded two sterol glycosides, stigmast-5,22-dien-3-O-β-D-glucoside (1a) and sitosterol-3-O-β-D-glucoside (1b), as a mixture. The compounds were found to be active against HeLa (IC50: 37.0±4.51 µg/mL) and MCF-7 (137.07±19.43 µg/mL) cell lines. The compounds showed strong interactions with the colchicine-binding site on the β-subunit of tubulin protein, epidermal growth factor receptor kinase domain, poly(ADP-ribose) polymerase-1, and 17β-hydroxysteroid dehydrogenase type 1 (binding energies: –10.3 and –10.0 kcal/mol; –9.3 and –9.3 kcal/mol; –9.2 and –9.2 kcal/mol; and –9.3 and –9.1 kcal/mol, respectively). Stigmast-5,22-dien-3-O-β-D-glucoside was consistently ranked higher in some of the proteins tested. The compounds stabilised in the binding sites of the proteins via hydrogen bonds and hydrophobic interactions. Conclusion: To the best of our knowledge, this is the first report of the isolation of these compounds from this plant. The cytotoxic effects of O. subscorpioidea root extract could be partly attributed to stigmast-5,22-dien-3-O-β-D-glucoside and sitosterol-3-O-β-D-glucoside.
- Open Access
- 1 June 2025
- Published by KEAI Publishing in Intelligent Pharmacy
- Vol. 3 (3) , 207-224
Artificial intelligence, computational tools and robotics for drug discovery, development, and delivery
- 1 June 2025
- Published by KEAI Publishing in Intelligent Pharmacy
- Vol. 3 (3) , 207-224
Open AccessArtificial intelligence, computational tools and robotics for drug discovery, development, and delivery